Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R V Jackson

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Journal of Diabetes and Its Complications|August 4, 1999
Polyneuropathy in Australian outpatients with type II diabetes mellitusC N de Wytt, R V Jackson, G I Hockings, et al.
Investigative Radiology|March 1, 1983
Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dogR J Workman, M I Shaff, R V Jackson, et al.
Neuromuscular Disorders : NMD|February 16, 2019
Respiratory dysfunction in myotonic dystrophy type 1: A systematic reviewA M Hawkins, C L Hawkins, K Abdul Razak, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1995
Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humansD J Torpy, J E Grice, G I Hockings, et al.
Clinical and Experimental Pharmacology & Physiology|February 1, 1994
Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humansD J Torpy, R V Jackson, J E Grice, et al.
Neuroendocrinology|February 1, 1995
A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormoneG I Hockings, J E Grice, M M Walters, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulationG I Hockings, J E Grice, G V Crosbie, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in manD J Torpy, J E Grice, G I Hockings, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axisD J Torpy, J E Grice, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humansD J Torpy, J E Grice, G I Hockings, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Journal of Diabetes and Its Complications|August 4, 1999
Polyneuropathy in Australian outpatients with type II diabetes mellitusC N de Wytt, R V Jackson, G I Hockings, et al.
Investigative Radiology|March 1, 1983
Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dogR J Workman, M I Shaff, R V Jackson, et al.
Neuromuscular Disorders : NMD|February 16, 2019
Respiratory dysfunction in myotonic dystrophy type 1: A systematic reviewA M Hawkins, C L Hawkins, K Abdul Razak, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1995
Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humansD J Torpy, J E Grice, G I Hockings, et al.
Clinical and Experimental Pharmacology & Physiology|February 1, 1994
Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humansD J Torpy, R V Jackson, J E Grice, et al.
Neuroendocrinology|February 1, 1995
A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormoneG I Hockings, J E Grice, M M Walters, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulationG I Hockings, J E Grice, G V Crosbie, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in manD J Torpy, J E Grice, G I Hockings, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1997
Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axisD J Torpy, J E Grice, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1994
Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humansD J Torpy, J E Grice, G I Hockings, et al.
Pageof 8